
KANABO GROUP PLC — Investor Relations & Filings
Kanabo Group PLC is a digital health company focused on the research, development, and commercialization of cannabis-derived products. The company distributes cannabis-derived formulations for medical patients and non-THC products for CBD consumers. Its research and development efforts create proprietary, patent-pending formulas for conditions such as sleep and central nervous system (CNS) disorders. A key component of its offering is the VapePod®, a medically certified vaporization device that enables precise, metered-dosing of cannabis extracts. The company also operates The GP Service, a telehealth platform providing digital health services, including video consultations and online prescriptions, which integrates primary care with its specialist medicine offerings.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Disposal of Subsidiary: The GP Service Limited | 2025-12-11 | English | |
| Appointment of Joint Administrators | 2025-11-28 | English | |
| Amended group accounts made up to 2023-12-31 | 2025-07-21 | English | |
| Temporary suspension of listing | 2025-04-30 | English | |
| Business Update | 2025-04-04 | English | |
| Resignation of Director | 2025-03-24 | English |
Browse filings by year
10 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
8 filings
| |||||
| 9837660 | Disposal of Subsidiary: The GP Service Limited | 2025-12-11 | English | ||
| 8791667 | Appointment of Joint Administrators | 2025-11-28 | English | ||
| 46832305 | Amended group accounts made up to 2023-12-31 | 2025-07-21 | English | ||
| 11347559 | Temporary suspension of listing | 2025-04-30 | English | ||
| 11333746 | Business Update | 2025-04-04 | English | ||
| 11326787 | Resignation of Director | 2025-03-24 | English | ||
| 5587221 | Revenue Growth, Trading and Operational Update | 2025-03-04 | English | ||
| 5562359 | Directorate Change | 2025-01-06 | English | ||
|
2024
7 filings
| |||||
| 2508215 | The GP Service Wins Award | 2024-11-19 | English | ||
| 5535629 | Correction Director/PDMR Shareholding | 2024-10-31 | English | ||
| 2381653 | Director/PDMR Shareholding | 2024-10-29 | English | ||
| 2319038 | Half-year Report | 2024-09-30 | English | ||
| 2079889 | Director/PDMR Shareholding | 2024-08-28 | English | ||
| 46832306 | Group of companies' accounts made up to 2023-12-31 | 2024-07-11 | English | ||
| 2052874 | Result of AGM | 2024-06-27 | English | ||
Financials
We couldn't load the financials
No data available yet
We have extracted financials for KANABO GROUP PLC, but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
BioNTech SE
Biotechnology company developing immunotherapies for cancer…
|
BNTX | DE | Manufacturing |
|
BioNxt Solutions Inc.
Clinical-stage developer of next-generation drug formulatio…
|
BNXT | CA | Manufacturing |
|
Biophage Pharma Inc.
Developing innovative phage-based therapies for antibiotic-…
|
BIPMF | CA | Manufacturing |
|
BioPorto
An in vitro diagnostics company specializing in biomarkers …
|
BIOPOR | DK | Manufacturing |
|
BIO-RAD LABORATORIES, INC.
Develops and manufactures products for life science and cli…
|
BIO | US | Manufacturing |
|
Biosergen AB
Develops drugs to treat severe and resistant invasive funga…
|
BIOSGN | SE | Manufacturing |
|
Biosino Bio-Technology and Science Incorporation
Major high-tech manufacturer of in-vitro diagnostic (IVD) p…
|
8247 | HK | Manufacturing |
|
BIOSIS GROUP BERHAD
Manufacturer of pharmaceutical, personal care, skincare, an…
|
— | MY | Manufacturing |
|
Bio Solution Co.,Ltd.
Develops cell therapies, human tissue models, and bio-labor…
|
086820 | KR | Manufacturing |
|
BioSyent Inc.
Specialty pharmaceutical company developing and commerciali…
|
RX | CA | Manufacturing |
KANABO GROUP PLC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/4978/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=4978 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=4978 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=4978 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 4978}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for KANABO GROUP PLC (id: 4978)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.